Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose randomized crossover bioequivalence study of febuxostat 80 mg vs Feburic in healthy Thai volunteers under fasting
TCTR20220822004Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of febuxostat (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
febuxostat
Beyond the preview
Go deeper on TCTR20220822004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220822004.